As of 2025-03-18, the Relative Valuation of Entheon Biomedical Corp (ENBI.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.15 CAD, the upside of Entheon Biomedical Corp based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-03-14 | -6.76 |
| 2025-03-13 | -6.76 |
| 2025-03-06 | -8.11 |
| 2025-03-04 | -11.04 |
| 2025-02-28 | -12.16 |
| 2025-02-27 | -13.51 |
| 2025-02-26 | -13.74 |
| 2025-02-25 | -13.74 |
| 2025-02-24 | -13.74 |
| 2025-02-21 | -13.96 |
| 2025-02-20 | -13.96 |
| 2025-02-19 | -13.96 |
| 2025-02-18 | -13.96 |
| 2025-02-14 | -15.09 |
| 2025-02-13 | -15.09 |
| 2025-02-07 | -16.44 |
| 2025-02-05 | -14.86 |
| 2025-02-04 | -14.41 |
| 2025-01-31 | -15.77 |
| 2025-01-30 | -16.22 |
| 2025-01-29 | -13.96 |
| 2025-01-28 | -16.89 |
| 2025-01-27 | -14.41 |
| 2025-01-24 | -18.02 |
| 2025-01-23 | -13.96 |
| 2025-01-22 | -13.96 |
| 2025-01-21 | -12.61 |
| 2025-01-16 | -12.16 |
| 2025-01-15 | -12.16 |
| 2025-01-14 | -12.16 |
| 2025-01-13 | -11.49 |
| 2025-01-10 | -12.39 |
| 2025-01-09 | -11.49 |
| 2025-01-07 | -12.61 |
| 2025-01-06 | -8.33 |
| 2025-01-03 | -8.11 |
| 2024-12-30 | -8.33 |
| 2024-12-27 | -11.04 |
| 2024-12-23 | -7.21 |